Calypte Biomedical Corp (fka CYPT)

[scion]

"...recommended on November 10, 2003 that the Company appoint two Marr representatives as members of its Board at a date on or after January 1, 2004, mutually agreeable to the Marr representatives and the Company."
Related Parties

On October 8, 2003, Marr Technologies B.V. filed a Schedule 13D/A and a Form 3
with the Securities & Exchange Commission reporting its ownership of
approximately 38.9 million shares of the Company's common stock and, on that
basis, identifying itself as a related party to the Company. Based on the number
of shares outstanding as of October 31, 2003, Marr owns approximately 28.5% of
the Company's outstanding shares of common stock. Further, pursuant to the
agreement in which Marr made its initial $2.5 million investment, the Nominating
Committee of the Company's Board of Directors recommended on November 10, 2003
that the Company appoint two Marr representatives as members of its Board at a
date on or after January 1, 2004, mutually agreeable to the Marr representatives
and the Company.

http://www.10kwizard.com/filing.php?param=repo%3Dtenk-exp%3D...